E&L Challenges During Pharmaceutical Drug Manufacturing and Development
Although the current guidelines for extractables and leachables (E&L) studies are general and the exact criteria for every situation or form of manufacturing, packaging, and delivery systems are not outlined, E&L risk assessment is critical to the pharmaceutical drug development process.
This white paper reviews the challenges E&L studies present to manufacturers, and demonstrates how a trusted laboratory partner can help overcome common problems faced during production and packaging.
To learn more about E&L challenges and solutions, download the free white paper below.
E&L Challenges During Pharmaceutical Drug Manufacturing and Development includes information on
- E&L supply chain complexities
- E&L container closure requirements
- E&L challenges that affect cost and turnaround times
- Selecting an analytical partner